Daewoong Pharmaceutical Co., Ltd 069620.KS Stock
Daewoong Pharmaceutical Co., Ltd Price Chart
Daewoong Pharmaceutical Co., Ltd 069620.KS Financial and Trading Overview
Daewoong Pharmaceutical Co., Ltd stock price | 112700 KRW |
Previous Close | 108600 KRW |
Open | 108600 KRW |
Bid | 107700 KRW x 0 |
Ask | 107700 KRW x 0 |
Day's Range | 107500 - 109500 KRW |
52 Week Range | 101700 - 195500 KRW |
Volume | 26.19K KRW |
Avg. Volume | 42.6K KRW |
Market Cap | 1.24T KRW |
Beta (5Y Monthly) | 1.05 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 600 (0.54%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | 165727 KRW |
069620.KS Valuation Measures
Enterprise Value | 1.67T KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.9502188 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.281 |
Enterprise Value/EBITDA | 12.182 |
Trading Information
Daewoong Pharmaceutical Co., Ltd Stock Price History
Beta (5Y Monthly) | 1.05 |
52-Week Change | -28.079% |
S&P500 52-Week Change | 20.43% |
52 Week High | 195500 KRW |
52 Week Low | 101700 KRW |
50-Day Moving Average | 110678 KRW |
200-Day Moving Average | 137150 KRW |
069620.KS Share Statistics
Avg. Volume (3 month) | 42.6K KRW |
Avg. Daily Volume (10-Days) | 28.84K KRW |
Shares Outstanding | 11.51M |
Float | 5.45M |
Short Ratio | N/A |
% Held by Insiders | 60.78% |
% Held by Institutions | 14.90% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 42.00% |
Payout Ratio | 0.1513 |
Last Split Factor | 1.03:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.37% |
Operating Margin (ttm) | 7.45% |
Gross Margin | 50.11% |
EBITDA Margin | 10.51% |
Management Effectiveness
Return on Assets (ttm) | 3.91% |
Return on Equity (ttm) | 5.27% |
Income Statement
Revenue (ttm) | 1.3T KRW |
Revenue Per Share (ttm) | 117534.29 KRW |
Quarterly Revenue Growth (yoy) | 8.09% |
Gross Profit (ttm) | 638.09B KRW |
EBITDA | 137.19B KRW |
Net Income Avi to Common (ttm) | 44.03B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 13.10% |
Balance Sheet
Total Cash (mrq) | 178.8B KRW |
Total Cash Per Share (mrq) | 15539.03 KRW |
Total Debt (mrq) | 441.85B KRW |
Total Debt/Equity (mrq) | 55.52 KRW |
Current Ratio (mrq) | 1.185 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 118.96B KRW |
Levered Free Cash Flow (ttm) | -24192974848 KRW |
Profile of Daewoong Pharmaceutical Co., Ltd
Country | South Korea |
State | N/A |
City | Seoul |
Address | 12, Bongeunsa-ro 114-gil |
ZIP | 135-715 |
Phone | 82 2 550 8209 |
Website | https://www.daewoong.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1715 |
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Q&A For Daewoong Pharmaceutical Co., Ltd Stock
What is a current 069620.KS stock price?
Daewoong Pharmaceutical Co., Ltd 069620.KS stock price today per share is 112700 KRW.
How to purchase Daewoong Pharmaceutical Co., Ltd stock?
You can buy 069620.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Daewoong Pharmaceutical Co., Ltd?
The stock symbol or ticker of Daewoong Pharmaceutical Co., Ltd is 069620.KS.
Which industry does the Daewoong Pharmaceutical Co., Ltd company belong to?
The Daewoong Pharmaceutical Co., Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Daewoong Pharmaceutical Co., Ltd have in circulation?
The max supply of Daewoong Pharmaceutical Co., Ltd shares is 11.51M.
What is Daewoong Pharmaceutical Co., Ltd Price to Earnings Ratio (PE Ratio)?
Daewoong Pharmaceutical Co., Ltd PE Ratio is now.
What was Daewoong Pharmaceutical Co., Ltd earnings per share over the trailing 12 months (TTM)?
Daewoong Pharmaceutical Co., Ltd EPS is 0 KRW over the trailing 12 months.
Which sector does the Daewoong Pharmaceutical Co., Ltd company belong to?
The Daewoong Pharmaceutical Co., Ltd sector is Healthcare.